1-1 Personalized Medicine in Allergy and Asthma

Friday, 13 December 2013: 08:05 - 08:30
Great Lakes Grand Ballroom (Westin - Michigan Avenue)

Elliot Israel, MD , Harvard University, Brigham and Women's Hospital, Harvard Medical School, Boston

Learning Objectives:
Indicate how genetic variation and endotypes influence responses to pharmacotherapy.

Deduce how component resolved allergen diagnosis and the use of allergens tailored to an individual's sensitization creates a unique opportunity for personalized medicine in allergy.

Compare and contrast the different inflammatory phenotypes of asthma and other chronic allergic diseases with involvement of different causative pathways and how it will lead to greater precision in targeting therapeutics, especially biologics.